[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341864-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341864-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dogs-evaluation-serum-soluble-interleukin-2-receptor-with-diagnosis-and-prognosis-in-canine-solid-tumour-34-cases","DOGS - Evaluation Serum Soluble Interleukin 2 Receptor With Diagnosis and Prognosis in Canine Solid Tumour: 34 Cases","","Soluble interleukin-2 receptor (sIL-2R) is evaluated as a blood biomarker for canine cancer by measuring serum concentrations in healthy dogs and in dogs with solid tumours. Serum from 6 healthy dogs and 34 dogs with solid tumours was analyzed using a commercial enzyme-linked immunosorbent assay. sIL-2R levels were higher in solid-mass dogs, highest in malignant tumours. Among malignant cases, higher sIL-2R associated with increased mortality.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dogs-evaluation-serum-soluble-interleukin-2-receptor-with-diagnosis-and-prognosis-in-canine-solid-tumour-34-cases/341864/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dogs-evaluation-serum-soluble-interleukin-2-receptor-with-diagnosis-and-prognosis-in-canine-solid-tumour-34-cases/341864.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study assessing as a biomarker in dogs?","Question",{"text":63,"@type":64},"The study assesses serum soluble interleukin-2 receptor (sIL-2R) as a potential biomarker for canine solid tumours, including diagnostic and prognostic value.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were sIL-2R levels measured?",{"text":68,"@type":64},"Serum samples were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship was found between sIL-2R and tumour type or outcome?",{"text":72,"@type":64},"sIL-2R concentrations were higher in dogs with solid masses than in healthy dogs, and among malignant tumours sIL-2R levels correlated with mortality rate, with higher levels associated with higher mortality.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341864,1790194008,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","DOI: 10.1002/vms3.70033  \nORIGINAL ARTICLE  \nDOGS  \nEvaluation serum soluble interleukin 2 receptor with diagnosis and prognosis in canine solid tumour: 34 cases  \nHyun NamKung1   Su-Min Park1, 2  Min-Ok Ryu1   Kyoung-Won Seo1   \n Jae-Hyeon Im1  Ga-Hyun Lim1   Hwa-Young Youn1   \n1 Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea  \n2 Haemaru Small Animal Clinical Research Institute, Seongnam, Republic of Korea  \nCorrespondence  \nHwa-Young Youn, Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, 1  \nGwanak-ro, Gwanak-gu, Seoul 00826, Republic of Korea.  \nEmail: [hyyoun@snu.ac.kr](hyyoun@snu.ac.kr)  \nAbstract  \nBackground/Aim: The soluble interleukin-2 receptor (sIL-2R) serve as a valuable biomarker for tumors in human patients, as its levels increase during the activation of T lymphocytes in clinical states such as inflammation, infection, and tumor. This study aimed to demonstrate that sIL-2R levels can be also elevated in dogs with tumors and evaluate its applicability asa diagnostic and prognostic factor incanine cancer patients. Patients and Methods: Serum was collectedfrom6healthy dogs and34dogs with solid tumors. The concentration of sIL-2R was measured using a commercial enzyme-linked immunosorbent assay kit.  \nResults: The median sIL-2R concentration was significantly higher in dogs with solid masses than in healthy dogs (117.3 vs 68.33 pg/ml, p = 0.016). The highest median sIL-2R concentration was found in dogs with malignant tumors, followed by those with benign tumors, and healthy dogs (119.6 vs 93.74 vs 68.33 pg/ml, respectively). In dogs with malignant tumors, the mortality rate was significantly higher in the group with high sIL-2R levels than in the group with low sIL-2R levels. Dogs with solid tumors, particularly those with malignant tumors, had higher concentrations of sIL-2R than healthy dogs. Among dogs with malignant tumors, a correlation between sIL-2R concentration and mortality rate was confirmed.  \nConclusion: Serum sIL-2R levels may be used to detect malignant tumors and serve asa prognostic factor in dogs with malignant tumors.  \nKEYWORDS  \ndog, malignant tumour, soluble interlukin-2 receptor, tumour biomarker  \n1  INTRODUCTION  \nCancer is a leading cause of death in companion animals. In the United States, more than 165 million companion animals are diagnosed with cancer annually, and at least 4 million dogs and cats each are diagnosed with cancer annually(Withrowetal., 2013). Many spontaneous tumour  \nHyun NamKung and Su-Min Park are co-first authors and contributed equally.  \ntypes are found in companion animals, including mammary tumours, osteosarcoma, hemangiosarcoma, lung cancer, skin cancer, prostate cancer and gastrointestinal cancers (Pinho et al., 2012).  \nIn veterinary medicine, it is difficult to diagnose cancer at an early stage; performing a biopsy, even after the cancer is detected, is challenging because of the cost and risk associated with anaesthesia. Therefore, biomarkers identified in the blood, urine and other body fluids of veterinary cancer patients will play an important role in  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2024 The Author(s). Veterinary Medicine and Science published by John Wiley & Sons Ltd.  \nVet Med Sci. 2024;10:e70033.  \n[https://doi.org/10.1002/vms3.70033](https://doi.org/10.1002/vms3.70033)  \nwi[leyonlinelibrary.com/journal/vms3](leyonlinelibrary.com/journal/vms3)  \n1of7  \n2of7  \nNAMKUNG ET AL.  \ntumour diagnosis, staging, prognosis and treatment-response monitoring (Brawley & Kramer, 2005; Colombe et al., 2022). In addition, as i","cbCait1sY06V4hWu","https://ap.wps.com/l/cbCait1sY06V4hWu","pdf",423824,"English","# Abstract\n## Background/Aim\n## Patients and Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and Methods\n## Patient selection and diagnosis","[{\"question\":\"What is the study assessing as a biomarker in dogs?\",\"answer\":\"The study assesses serum soluble interleukin-2 receptor (sIL-2R) as a potential biomarker for canine solid tumours, including diagnostic and prognostic value.\"},{\"question\":\"How were sIL-2R levels measured?\",\"answer\":\"Serum samples were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit.\"},{\"question\":\"What relationship was found between sIL-2R and tumour type or outcome?\",\"answer\":\"sIL-2R concentrations were higher in dogs with solid masses than in healthy dogs, and among malignant tumours sIL-2R levels correlated with mortality rate, with higher levels associated with higher mortality.\"}]","DOGS - Evaluation Serum Soluble Interleukin 2 Receptor With Diagnosis and Prognosis in Canine Solid Tumour: 34 Cases | PDF",1790044201,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12f512ff3c9a368138d2850dcce1bd82.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/217508a501ab9d2df2d7eed637879c21.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/881958cfeaddee43de1db33fa3a84eb5.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/120efacbbbb3fbbe31d0aec9585ceb9f.webp",980,1287]